Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Younes
Improving T-Cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4
Clinical Cancer Research
Cancer Research
Oncology
Simulation of Rock Salt Dissolution and Its Impact on Land Subsidence
Hydrology and Earth System Sciences
Earth
Water Science
Planetary Sciences
Technology
Incidence and Treatment Outcomes of Patients With Transformed Marginal Zone Lymphoma Treated With Rchop-Like Regimens
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Autologous Transplant: Full Results After Extended Follow-Up of the Phase 2 Checkmate 205 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Impact of Pet Imaging and Histologic Transformation on the Prognosis of Early Disease Progression in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety and Early Data From a Phase Ii Trial of Pembrolizumab (Pem) and Entinostat (Ent) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (Hl) and Follicular Lymphoma (Fl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Dose Finding Study to Assess Safety, Pk and Efficacy of Fimepinostat (Cudc-907) With Venetoclax or Rituximab Plus Bendamustine in Patients With Relapsed/Refractory Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ezh2 Gain-Of-Function Mutations Are Not Associated With More Favorable Prognosis in Relapsed/Refractory Follicular Lymphoma (Fl): A Preliminary Analysis on 590 Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
